血管性头痛行高压氧联合西比灵治疗与护理体会

目的:研究高压氧治疗血管性头痛的近期疗效与远期疗效。方法:将132例患者随机分为对照组和高压氧治疗组,每组66例。对照组给予西比灵5~10mg口服,每晚1次,肠溶阿斯匹林25mg/次,3次/d,10d为1疗程。治疗组在药物治疗的基础上加用高压氧治疗。观察两组患者头痛、头晕、恶心、呕吐症状消失情况及半年内复发情况。结果:高压氧治疗组头痛、头晕、恶心、呕吐症状消失较对照组快,总有效率比较有显著性差异(P<0.01)。结论:高压氧联合西比灵治疗血管性头痛显效快、有效率高、远期疗效好。     

血管性头痛行高压氧联合西比灵治疗与护理体会

目的：研究高压氧治疗血管性头痛的近期疗效与远期疗效。方法：将132例患者随机分为对照组和高压氧治疗组，每组66例。对照组给予西比灵5-10mg口服，每晚1次，肠溶阿斯匹林25mg／次，3次／d，10d为1疗程。治疗组在药物治疗的基础上加用高压氧治疗。观察两组患者头痛、头晕、恶心、呕吐症状消失情况及半年内复发情况。结果：高压氧治疗组头痛、头晕、恶心、呕吐症状消失较对照组快，总有效率比较有显著性差异（P〈0．01）。结论：高压氧联合西比灵治疗血管性头痛显效快、有效率高、远期疗效好。     

川芎清脑颗粒治疗脑梗死后头痛、头晕伴失眠的研究

目的 观察川芎清脑颗粒治疗脑梗死后头晕、头痛伴失眠的临床疗效.方法 320例脑梗死后头晕、头痛伴失眠患者,根据随机数字表法分为治疗组和对照组,每组160例.治疗组给予川芎清脑颗粒10 mg/次,3次/d,口服;对照组给予西比灵胶囊10 mg,1次/晚,睡前口服.连续给药4周.对两组患者治疗前、治疗2周后及治疗4周后的VAS疼痛评分进行比较,并对两组患者的头痛、头晕及失眠的整体临床疗效以及不良反应进行比较.结果 治疗2、4周后治疗组的VAS疼痛评分显著低于对照组,差异均有统计学意义（t值分别为5.199、18.00,P均＜0.05）;治疗1个月后,治疗组的治愈率和总有效率显著高于对照组差异均有统计学意义（31.9％与21.3％,86.9％与77.5％;x2值分别为4.630、4.803,P均＜0.05）.结论 川芎清脑颗粒能够有效改善脑梗死后头晕、头痛伴失眠的症状,是临床值得推广的治疗方案.     

抗抑郁药与西比灵联合治疗血管性头痛疗效观察

目的：观察抗抑郁药与西比灵联合治疗血管性头痛的疗效。方法：随机将182例血管性头痛患者分为治疗组（抗抑郁药联合西比灵）91例与对照组（单纯西比灵）91例,对比观察疗效。结果：治疗组显效率为88%,对照组为58%。两组差异有显著性（P〈0.05）。说明治疗组疗效优于对照组。结论：抗抑郁药与西比灵联合治疗血管性头痛疗效确切。     

川芎清脑颗粒联合西比灵治疗偏头痛临床观察

目的观察川芎清脑颗粒与西比灵联合治疗偏头痛的疗效。方法将120例偏头痛的患者随机分成川芎清脑颗粒联合西比灵组60例（治疗组）和单用西比灵组（对照组）60例。治疗组给予川芎清脑颗粒10 g次/,3次/d,口服;西比灵10 mg,1次/晚,口服。对照组给予西比灵10 mg,1次/晚,口服,疗程均为4周。结果川芎清脑颗粒联合西比灵治疗偏头痛的总有效率明显高于单用西比灵（P〈0.05）。结论川芎清脑颗粒是一种有效的治疗偏头痛的药物,与西比灵合用可提高疗效。     

莫沙必利与氟西汀联用治疗功能性消化不良的疗效观察

目的　评价莫沙必利联用氟西汀治疗功能性消化不良 (FD)的疗效。方法　将 10 2例FD患者随机分为 2组。观察组 5 4例 ,给予莫沙必利 5mg ,3次 /d ,氟西汀 2 0mg ,1次 /d ;对照组 4 8例 ,给予莫沙必利 5mg ,3次 /d。疗程均为 4周 ,比较两组临床症状的变化。 结果　观察组与对照组用药 4周后临床主要症状均明显缓解 (P <0 .0 1或 0 .0 5 ) ;除恶心、呕吐和上腹部疼痛外 ,其他症状消失率观察组均优于对照组。观察组治疗总有效率为 90 .7% ,对照组为 75 .0 % ,两组相比 ,差异有显著性意义 (P <0 .0 5 )。两组患者均无严重不良反应。结论　莫沙必利联用氟西汀治疗FD疗效满意 ,安全性好 ,是目前治疗FD的可行方案。     

口服利君沙片致胃肠型过敏反应一例

1 病例资料 患者,女,55岁.2006年9月20日上午在拔牙后给予利君沙0.375 g,3次,d,服药3次后出现中上腹部疼痛、恶心、呕吐,故停用利君沙,给予口服胃舒平片2片,3次/d,胃复安10 mg,肌注,症状暂时减轻.4 h后症状再次加重,给予吗丁啉10 mg,3次/d,症状无减轻.9月21日患者皮肤出现散在皮疹,仍感上腹痛、恶心,给予扑尔敏4mg,3次/d,服用扑尔敏后约0.5 h患者腹痛减轻,恶心、呕吐症状缓解,1 d后上腹部症状完全消失,皮疹消失.     

纳美芬治疗儿童危重症手足口病136例疗效观察

目的观察纳美芬治疗儿童危重症手足口病的疗效。方法将136例符合诊断标准的儿童危重症手足口病的患儿随机分成治疗组和对照组,治疗组72例,对照组64例。在相同综合治疗及抗病毒[病毒唑10 mg/（Kg.d）]的基础上,治疗组加用盐酸纳美芬治疗（0.1 mg/次,1～2次/d）,观察患儿发热、呕吐、惊颤及意识恢复等情况。结果治疗组患儿在退热时间、呕吐消失时间、惊颤消失时间及意识恢复时间等方面明显优于对照组,两组比较差异有统计学意义（P〈0.01）。结论纳美芬治疗儿童危重症手足口病疗效显著。     

中西医结合治疗脑外伤反应80例

目的探讨中西医结合在脑外伤反应治疗中的作用。方法将 12 0例脑外伤反应患者分成两组 :治疗组 (80例 )在综合措施治疗的基础上 ,使用理气开窍汤 ;对照组 (4 0例 )按综合措施治疗。观察治疗 2 0d内患者头痛、头昏、耳鸣、恶心呕吐、失眠症状改善情况。结果临床症状有效率比较 ,两组有显著性差异 (P <0 0 5 )。结论理气开窍汤配以高压氧及营养神经类药物 ,可明显提高疗效。     

长春胺缓释胶囊治疗血管性认知功能障碍:与尼莫地平的对照

目的:观察长春胺缓释胶囊治疗血管性认知障碍的疗效,并与尼莫地平片进行比较.方法:选取血管性认知功能障碍患者120例,按患者意愿随机分为治疗组与对照组,每组60例.治疗组口服长春胺缓释胶囊,30 mg,次,2次/d,对照组口服尼莫地平片,30 mg,次,3次/d,疗程均为6个月.观察临床疗效、简易精神状态量表和日常生活能力量表得分情况.结果:长春胺缓释胶囊治疗组总有效率60.0%,尼莫地平对照组总有效率53.3%,两组比较差异有显著意义(P<0.05);两组治疗前、后简易精神状态量表、日常生活能力量表得分情况比较,均有明显的改善(P<0.01),两组治疗后比较差异有显著意义(P<0.05);药物不良反应治疗组明显少于对照组.结论:长春胺缓释胶囊治疗血管性认知功能障碍疗效肯定,不良反应少.     

超声评分对膝骨性关节炎患者病变特点的评估价值

目的 探讨超声评分对膝骨性关节炎患者病情严重度的诊断价值。方法 回顾性收集我院收治的膝骨性关节炎患者52例,同期收集50例健康成人,分析超声评分与膝骨性关节炎患者病情严重度的相关性。结果 膝骨性关节炎患者超声评分显著高于健康成人(6.93±1.76 vs. 1.73±0.56,P=0.000)。膝骨性关节炎患者超声评分与髌上囊液体深度、髌下囊液体深度、关节腔液体深度、滑膜厚度显著正相关(r=0.265、0.216、0.310和0.255,P=0.004、0.035、0.000和0.012),与Lyshsolm显著负相关(r=-0.381,P=0.000)。与增生滑膜内血管阴性的患者相比,增生滑膜内血管阳性的患者超声评分显著增加(7.43±1.61 vs. 5.58±1.42, P=0.000)。结论 超声评分与膝骨性关节炎患者病情严重度相关。     

Use of the Role Checklist with the patient with multiple personality disorder

A paucity of occupational therapy evaluation tools exists for use with patients with multiple personality disorder. The Model of Human Occupation (Kielhofner & Burke, 1980), particularly the volition and habituation subsystems within this model, proved useful for the identification of the many facets of patients with multiple personality disorder on a short-term treatment unit. The Role Checklist (Oakley, Kielhofner, Barris, & Richler, 1986), a tool derived from the Model of Human Occupation, was adapted for use with this population and was found to be beneficial in the identification of common goals held by most of the personalities of each patient with multiple personality disorder. The use of the Role Checklist is illustrated with a case example.     

Living with a woman with fibromyalgia from the perspective of the husband

BACKGROUND: Fibromyalgia (FM) is a chronic pain syndrome, which affects mostly middle-aged women. The syndrome is poorly understood and treatment is mainly palliative. The diagnosis is established from diagnostic criteria. Living with FM means living a life greatly influenced by the illness in various ways for people affected. Aim of the study. The aim of this study was to describe the experiences of living with a woman with FM from the husbands' perspective. METHODS: Five men married to women with FM were interviewed using a narrative approach. The interviews were analysed using qualitative thematic content analysis. FINDINGS: The analysis resulted in the following seven themes: increasing responsibility and work in the home; being an advocate for and supporting the wife; learning to see the woman's changing needs; changing relationship between spouses; changing relationship with friends and relatives; deepening relationship with the children and lacking information and knowledge about FM. The findings show that the women's illness had a great impact on husbands' lives, and that husbands lacked information about the woman's illness. CONCLUSION: This study shows that it is not only the women with FM who experience a changed life; the whole family life is influenced and limited by FM. The husband's role in the family changes, first and foremost concerning responsibility and workload within the family. This must be taken into consideration in care planning. This study also highlighted the need of information and knowledge about FM expressed by the participants, information that health care personnel have a great responsibility to give.     

Experience with the use of plasmapheresis in the combined treatment of children with the crush syndrome

Plasmapheresis (PP) was applied to the treatment of 5 children aged 6-14 years with the crush syndrome. The multimodality treatment using antibiotics, erythrocytic mass, rheologically active preparations, hemodialysis and blood rheologically active preparations, hemodialysis and hemoperfusion carried out for 6-7 days before PP did not bring about any appreciable improvement of the patients' status. The patients failed to get rid of anuria and manifested the signs of increasing intoxication. The treatment with PP consisted of 1 to 6 procedures, in the course of which 70 to 85 of the design volume of the circulating plasma was removed. The use of PP resulted in the disappearance of myoglobin from the patients' blood and urine, in the normalization of the coagulogram, a considerable decrease of the content of medium molecules, and in the appearance of the first urine towards the end of the procedure. Thus, the introduction of PP into multimodality treatment of the crush syndrome made it possible to eliminate anuria, disseminated intravascular coagulation, and to noticeably reduce intoxication and to clear the blood off myoglobin.